154
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Escalation of Osteosarcoma Stem Cells Apoptosis After the Co-Cultivation of Peripheral Blood Mononuclear Cells Sensitized with Mesenchymal Stem Cells Secretome and Colony Stimulating Factor-2 in vitro

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 601-611 | Published online: 08 Jul 2021

References

  • Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC Press; 2013.
  • Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.
  • Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(7):320–325. doi:10.1093/annonc/mdq276
  • Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D, Atlas of Musculoskeletal Tumors and Tumorlike Lesions [Internet]. Cham: Springer International Publishing; 2014 [cited 2017 September 12.]. Available from: http://link.springer.com/10.1007/978-3-319-01748-8. Accessed June 28, 2021.
  • Khan S, Barwar N, Kumar V. Surface osteosarcomas: diagnosis, treatment and outcome. Indian J Orthop. 2014;48(3):255. doi:10.4103/0019-5413.132503
  • Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg. 2016;82(4):690–698.
  • Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 2017;13(4):357–368. doi:10.2217/fon-2016-0261
  • Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–735.
  • Goldar S, Khaniani MS, Derakhshan SM, Baradaran B. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev. 2015;16(6):2129–2144. doi:10.7314/APJCP.2015.16.6.2129
  • Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417.
  • Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 2000;7(12):1166–1173. doi:10.1038/sj.cdd.4400783
  • Fang F, Xiao W, Tian Z. Challenges of NK cell-based immunotherapy in the new era. Front Med. 2018;12(4):440–450. doi:10.1007/s11684-018-0653-9
  • Horinaka M. Application of molecular-targeting cancer prevention to tumor immunity. Nihon Eiseigaku Zasshi. 2014;69(1):8–14. doi:10.1265/jjh.69.8
  • Xie Y, Chen B, Wang H, Wang K, Li R. Advances in the research of peripheral blood mononuclear cell-derived multipotential cell. Zhonghua Shao Shang Za Zhi. 2016;32(12):762–764. doi:10.3760/cma.j.issn.1009-2587.2016.12.013
  • Lötvall J, Rajendran L, Gho YS, et al. The launch of Journal of Extracellular Vesicles (JEV), the official journal of the International Society for Extracellular Vesicles - about microvesicles, exosomes, ectosomes and other extracellular vesicles. J Extracell Vesicles. 2012;16;1. doi:10.1016/0006-2952(75)90016-7
  • Arellano M, Waller K. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines. Curr Hematol Rep. 2004;3(6):424–431.
  • van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist. 2006;11(4):397–408. doi:10.1634/theoncologist.11-4-397
  • von Karstedt S, Montinaro A, Walczak H. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat Rev Cancer. 2017;17(6):352–366.
  • Chaudhry GE, Jan R, Naveed Zafar M, Mohammad H, Muhammad TST. Vitex Rotundifolia Fractions Induced Apoptosis in Human Breast Cancer T-47D Cell Line via Activation of Extrinsic and Intrinsic Pathway. Asian Pac J Cancer Prev. 2019;20(12):3555–3562. doi:10.31557/APJCP.2019.20.12.3555
  • Brune JC, Tormin A, Johansson MC, et al. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts. Int J Cancer. 2011;129(2):319–330. doi:10.1002/ijc.25697
  • Le Nail LR, Brennan M, Rosset P, et al. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma. Int J Mol Sci. 2018;19(3):707. doi:10.3390/ijms19030707
  • Skoda J, Nunukova A, Loja T, et al. Cancer stem cell markers in pediatric sarcomas: sox2 is associated with tumorigenicity in immunodeficient mice. Tumour Biol. 2016;37(7):9535–9548. doi:10.1007/s13277-016-4837-0
  • Adhikari AS, Agarwal N, Wood BM, et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res. 2010;70(11):4602–4612. doi:10.1158/0008-5472.CAN-09-3463
  • Menendez ST, Rey V, Martinez-Cruzado L, et al. SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications. Cancers. 2020;12(4):964. doi:10.3390/cancers12040964
  • Mahyudin F, Yazid H, Edward M, Basuki MH, Bari YA, Rantam FA. The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor. J Adv Pharm Technol Res. 2020;11:213–219. doi:10.4103/japtr.JAPTR_52_20
  • Sagaradze G, Grigorieva O, Nimiritsky P, et al. Conditioned Medium from Human Mesenchymal Stromal Cells: towards the Clinical Translation. Int J Mol Sci. 2019;20(7):1656. doi:10.3390/ijms20071656
  • Anderson J, Toh ZQ, Reitsma A, Do LAH, Nathanielsz J, Licciardi PV. Effect of peripheral blood mononuclear cell cryopreservation on innate and adaptive immune responses. J Immunol Methods. 2019;465:61–66. doi:10.1016/j.jim.2018.11.006
  • Maumus M, Jorgensen C, Noël D. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie. 2013;95(12):2229–2234. doi:10.1016/j.biochi.2013.04.017
  • Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. doi:10.1002/jcp.26429
  • Secchiero P, Rimondi E, Agnoletto C. C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. Clin Cancer Res. 2013;19(8):1949–1959. doi:10.1158/1078-0432.CCR-12-3027
  • Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Yoshimura T. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology. 2004;111(2):186–194. doi:10.1111/j.0019-2805.2003.01794.x
  • Munoz LE, Franz S, Pausch F. The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J Leukoc Biol. 2007;81(1):6–14. doi:10.1189/jlb.0306166
  • Zhou D, Huang C, Lin Z, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014;26(2):192–197. doi:10.1016/j.cellsig.2013.11.004
  • Fritsch M, Günther SD, Schwarzer R, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575(7784):683–687. doi:10.1038/s41586-019-1770-6
  • Wang W, Zhu M, Xu Z, et al. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity. Biol Res. 2019;52(1):36. doi:10.1186/s40659-019-0242-7
  • Yang Q, Li S, Fu Z, et al. Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma. Mol Med Rep. 2017;16(2):1347–1352. doi:10.3892/mmr.2017.6729